Cargando…
The immune landscape of undifferentiated pleomorphic sarcoma
INTRODUCTION: Undifferentiated pleomorphic sarcoma (UPS) can be associated with a relatively dense immune infiltration. Immune checkpoint inhibitors (anti-PD1, anti-PDL1, and anti-CTLA4) are effective in 20% of UPS patients. We characterize the immune microenvironment of UPS and its association with...
Autores principales: | Lazcano, Rossana, Barreto, Carmelia M., Salazar, Ruth, Carapeto, Fernando, Traweek, Raymond S., Leung, Cheuk H., Gite, Swati, Mehta, Jay, Ingram, Davis R., Wani, Khalida M., Vu, Kim-Anh T., Parra, Edwin R., Lu, Wei, Zhou, Jianling, Witt, Russell G., Cope, Brandon, Thirasastr, Prapassorn, Lin, Heather Y., Scally, Christopher P., Conley, Anthony P., Ratan, Ravin, Livingston, J. Andrew, Zarzour, Alexandra M., Ludwig, Joseph, Araujo, Dejka, Ravi, Vinod, Patel, Shreyaskumar, Benjamin, Robert, Wargo, Jennifer, Wistuba, Ignacio I., Somaiah, Neeta, Roland, Christina L., Keung, Emily Z., Solis, Luisa, Wang, Wei-Lien, Lazar, Alexander J., Nassif, Elise F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597628/ https://www.ncbi.nlm.nih.gov/pubmed/36313661 http://dx.doi.org/10.3389/fonc.2022.1008484 |
Ejemplares similares
-
Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022) -
Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022) -
Emerging Data on the Safety and Efficacy of Ripretinib for the Treatment of Gastrointestinal Stromal Tumors
por: Thirasastr, Prapassorn, et al.
Publicado: (2023) -
Case report: Responses to the combination of gemcitabine with sirolimus in two patients with TSC-mutated sarcomas
por: Nassif, Elise F., et al.
Publicado: (2023) -
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma
por: Parkes, Amanda, et al.
Publicado: (2020)